Register for real-time alerts, custom portfolio, and market movers
BioTech
Aveo Pharma's FDA Adcomm on May 2nd Presents Run-Up Trade Potential
Apr 12 2013 @ 09:39
The advent of The Affordable Care act (Obama Care) on the horizon as the healthcare sector of the market continues...
2 Small Caps To Watch - ADTN and OMER
Apr 10 2013 @ 10:29
SmallCapReview.com, A leading site for news and information on small caps, penny stocks and microcaps is adding...
AVEO Pharma's Tivozanib Likely To Be Approved
Mar 27 2013 @ 10:56
With the current record market run, small cap biopharmas have kept pace and continue to trend higher, being one of...
Opexa Therapeutics: A Significant Growth Opportunity For Both Short Term Traders And Long Term Investors
Mar 25 2013 @ 10:51
As regenerative medicine continues to slowly bridge the gap between its future promise and the scientific reality of...
The Other Merck Soars on Liquid Crystal Business
Mar 23 2013 @ 14:00
Germany’s second leading pharmaceutical firm and one of the biggest family controlled organizations in this sector...
Antares Pharma ($ATRS) Quietly Being Accumulated, Set Up For Breakout
Mar 22 2013 @ 09:41
Antares Pharma (ATRS) is being set up to run to at least $3.85, Thesis follows below; The chart above shows “quiet”...
Obagi Acquired by Valeant, Are There Other Biotech Acquisitions Coming?
Mar 21 2013 @ 13:11
Yesterday, Obagi Medical Products (OMPI) was acquired by Valeant Pharmaceuticals (VRX) for $19.75 a share in an all...
Significant Catalysts And Company PR Error Present Significant Opportunity In AcelRx Pharmaceuticals
Mar 17 2013 @ 20:24
By Scott Matusow twitter.com/scottmatusow With The positive result of the first phase III study, coupled with the...
AcelRx Pharma Selloff Caused By Error In Recent Press Release
Mar 15 2013 @ 13:29
On March 12th, Acelrx (ACRX) released a pr covering its last quarter’s earnings. In the pr, the company stated...
AcelRx Pharma Poised to Move Higher on Technicals and Latest News
Mar 06 2013 @ 11:44
$ACRX Trade Call – Target $5.75 Yesterday, AcelRX said its Sufentanil NanoTab patient-controlled analgesia (PCA...
